359 related articles for article (PubMed ID: 9824312)
21. LL5beta directs the translocation of filamin A and SHIP2 to sites of phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) accumulation, and PtdIns(3,4,5)P3 localization is mutually modified by co-recruited SHIP2.
Takabayashi T; Xie MJ; Takeuchi S; Kawasaki M; Yagi H; Okamoto M; Tariqur RM; Malik F; Kuroda K; Kubota C; Fujieda S; Nagano T; Sato M
J Biol Chem; 2010 May; 285(21):16155-65. PubMed ID: 20236936
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
23. The mouse SHIP2 (Inppl1) gene: complementary DNA, genomic structure, promoter analysis, and gene expression in the embryo and adult mouse.
Schurmans S; Carrió R; Behrends J; Pouillon V; Merino J; Clément S
Genomics; 1999 Dec; 62(2):260-71. PubMed ID: 10610720
[TBL] [Abstract][Full Text] [Related]
24. Translocation between membranes and cytosol of p42IP4, a specific inositol 1,3,4,5-tetrakisphosphate/phosphatidylinositol 3,4, 5-trisphosphate-receptor protein from brain, is induced by inositol 1,3,4,5-tetrakisphosphate and regulated by a membrane-associated 5-phosphatase.
Stricker R; Adelt S; Vogel G; Reiser G
Eur J Biochem; 1999 Oct; 265(2):815-24. PubMed ID: 10504414
[TBL] [Abstract][Full Text] [Related]
25. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.
Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG
Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675
[TBL] [Abstract][Full Text] [Related]
27. Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase.
Drayer AL; Pesesse X; De Smedt F; Woscholski R; Parker P; Erneux C
Biochem Biophys Res Commun; 1996 Aug; 225(1):243-9. PubMed ID: 8769125
[TBL] [Abstract][Full Text] [Related]
28. A high-throughput microfluidic assay for SH2 domain-containing inositol 5-phosphatase 2.
Rowe T; Hale C; Zhou A; Kurzeja RJ; Ali A; Menjares A; Wang M; McCarter JD
Assay Drug Dev Technol; 2006 Apr; 4(2):175-83. PubMed ID: 16712421
[TBL] [Abstract][Full Text] [Related]
29. The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.
Batty IH; van der Kaay J; Gray A; Telfer JF; Dixon MJ; Downes CP
Biochem J; 2007 Oct; 407(2):255-66. PubMed ID: 17672824
[TBL] [Abstract][Full Text] [Related]
30. Comparative mechanistic and substrate specificity study of inositol polyphosphate 5-phosphatase Schizosaccharomyces pombe Synaptojanin and SHIP2.
Chi Y; Zhou B; Wang WQ; Chung SK; Kwon YU; Ahn YH; Chang YT; Tsujishita Y; Hurley JH; Zhang ZY
J Biol Chem; 2004 Oct; 279(43):44987-95. PubMed ID: 15316017
[TBL] [Abstract][Full Text] [Related]
31. Metabolic switching of PI3K-dependent lipid signals.
Downes CP; Leslie NR; Batty IH; van der Kaay J
Biochem Soc Trans; 2007 Apr; 35(Pt 2):188-92. PubMed ID: 17371235
[TBL] [Abstract][Full Text] [Related]
32. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP.
Pesesse X; Deleu S; De Smedt F; Drayer L; Erneux C
Biochem Biophys Res Commun; 1997 Oct; 239(3):697-700. PubMed ID: 9367831
[TBL] [Abstract][Full Text] [Related]
33. Phosphoinositide phosphatases: just as important as the kinases.
Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
Zhang J; Walk SF; Ravichandran KS; Garrison JC
J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
[TBL] [Abstract][Full Text] [Related]
35. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Ibrahim S; Sorisky A
J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the substrate specificity of the inositol 5-phosphatase SHIP1.
Nelson N; Wundenberg T; Lin H; Rehbach C; Horn S; Windhorst S; Jücker M
Biochem Biophys Res Commun; 2020 Apr; 524(2):366-370. PubMed ID: 32005521
[TBL] [Abstract][Full Text] [Related]
37. How does SHIP1/2 balance PtdIns(3,4)P2 and does it signal independently of its phosphatase activity?
Xie J; Erneux C; Pirson I
Bioessays; 2013 Aug; 35(8):733-43. PubMed ID: 23650141
[TBL] [Abstract][Full Text] [Related]
38. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
39. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2.
Kavanaugh WM; Pot DA; Chin SM; Deuter-Reinhard M; Jefferson AB; Norris FA; Masiarz FR; Cousens LS; Majerus PW; Williams LT
Curr Biol; 1996 Apr; 6(4):438-45. PubMed ID: 8723348
[TBL] [Abstract][Full Text] [Related]
40. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
